Skip to main content
SanBio Company Limited logo

SanBio Company Limited — Investor Relations & Filings

Ticker · 4592 ISIN · JP3336750009 T Professional, scientific and technical activities
Open in API
Filings indexed 75 across all filing types
Latest filing 2026-04-23 Declaration of Voting R…
Country JP Japan
Listing T 4592

About SanBio Company Limited

https://www.sanbio.com/en/

SanBio Company Limited is a regenerative medicine company focused on the research, development, and commercialization of cell-based therapies for neurological disorders. The company develops treatments intended to restore lost nerve function in patients with central nervous system conditions. Its lead product, AKUUGO® (development code: SB623), is a proprietary, allogeneic cell therapy derived from bone marrow stromal cells. It is administered via intracranial implantation and is developed for treating chronic motor deficits resulting from traumatic brain injury and ischemic stroke.

Recent filings

Filing Released Lang Actions
臨時報告書
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a Japanese “臨時報告書” filed after the company’s 13th Annual General Meeting held on April 22, 2026. It outlines the resolutions passed (election of a director and reduction of capital and reserves), and, critically, it provides the detailed voting results (number of votes for, against, abstentions, approval thresholds, and percentage approvals). This aligns exactly with “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA), which covers official results from shareholder votes at any general meeting.
2026-04-23 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の４の２第１項' (Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of a previously filed Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2026
2026-04-20 Japanese
有価証券報告書－第13期(2025/02/01－2026/01/31)
Annual Report Classification · 1% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of a 10-K annual report. It contains detailed financial statements, management indicators, and corporate information for the fiscal year ending January 31, 2026. It is not an announcement or a summary, but the full regulatory filing submitted to the Kanto Local Finance Bureau. FY 2026
2026-04-20 Japanese
訂正臨時報告書
Share Issue/Capital Change Classification · 1% confidence The document is a 'Temporary Report' (臨時報告書) filed with the Kanto Local Finance Bureau by SanBio Company Limited. It details the issuance of stock acquisition rights (新株予約権) to employees, including terms such as exercise price, quantity, and conditions. This type of regulatory filing in Japan, which discloses specific corporate events like share-based compensation or capital changes, is classified as a 'Share Issue/Capital Change' (SHA) as it pertains to the issuance of new equity-linked instruments.
2026-01-27 Japanese
訂正臨時報告書
Share Issue/Capital Change Classification · 1% confidence The document is a 'Rinji Hokokusho' (Extraordinary Report) filed with the Kanto Local Finance Bureau in Japan. It details a new share issuance (capital increase) for SanBio Company Limited, including the number of shares, pricing, and the intended use of proceeds. This falls under the category of 'Share Issue/Capital Change' (SHA) as it describes the issuance of new shares and the resulting capital structure changes.
2025-11-07 Japanese
確認書
Regulatory Filings
2025-09-12 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.